Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

WT1 and interferon-β-vitamin D association in MS: a longitudinal study.
Opinion: Focus on preclinical sex differences will not address women's and men's health disparities.
Regulatory T Cells Contribute to the Inhibition of Radiation-Induced Acute Lung Inflammation via Bee Venom Phospholipase A₂ in Mice.
Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers.
Product Portfolio, Meda
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome.
A Safety and Efficacy Extension Study of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS).
The impact of multiple sclerosis relapse treatment on migration of effector T cells - Preliminary study.
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial.
Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: The DEFINE study.
Mitoxantrone exerts both cytotoxic and immunoregulatory effects on activated microglial cells.
Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound.
Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA
Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases.
Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.
Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study.
Pathogenic implications of iron accumulation in multiple sclerosis.
Dimethyl Fumarate Protects Brain From Damage Produced by Intracerebral Hemorrhage by Mechanism Involving Nrf2.
Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial.
Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomas.
Ethnicity and prevalence of multiple sclerosis in east London.
EU regulator warns on possible MS drugs side effects
195 How Well Do Neuroradiologists Predict the Side of Trigeminal Neuralgia?
Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes.

Pages